DekaBank Deutsche Girozentrale »

Crispr Therapeutics shares owned by DekaBank Deutsche Girozentrale

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by DekaBank Deutsche Girozentrale from 13F filings

Historical chart of DekaBank Deutsche Girozentrale investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by DekaBank Deutsche Girozentrale consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by DekaBank Deutsche Girozentrale

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.8M 41k 68.46
2023-12-31 $2.6M 40k 64.30
2023-09-30 $1.8M 40k 45.75
2023-06-30 $2.3M 40k 57.03
2023-03-31 $883k 20k 44.15
2022-12-31 $841k 21k 40.33
2022-09-30 $1.3M 20k 65.20
2022-06-30 $2.9M 46k 63.01
2022-03-31 $2.9M 46k 64.08
2021-12-31 $2.7M 35k 76.76
2021-09-30 $5.6M 51k 110.21
2021-06-30 $6.7M 45k 150.52
2021-03-31 $4.2M 36k 115.20
2020-12-31 $2.6M 16k 157.82
2020-09-30 $1.1M 14k 84.98